Morphic Competitors

Summary

Morphic Holding competes with Arcellx, Ventyx Biosciences, Immunocore Holdings, Vaxcyte, and 89bio; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Morphic Holding competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Morphic Holding to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Morphic Holding competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
0.00	0.00	0.00

Details

Intrinsic

Valuation

Low	Real	High
0.00	0.00	0.00

Details

Morphic Holding Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Morphic Holding and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Morphic and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Morphic Holding does not affect the price movement of the other competitor.

	ACLX	VTYX	IMCR	PCVX	DICE	ETNB	MDGL	PLRX	STOK
ACLX		0.06	-0.17	-0.01	0.55	0.26	0.45	0.5	-0.36	ACLX
VTYX	0.06		0.16	0.45	-0.29	0.09	-0.33	0.24	0.25	VTYX
IMCR	-0.17	0.16		-0.25	0.02	0.69	0.2	0.44	0.69	IMCR
PCVX	-0.01	0.45	-0.25		-0.43	-0.42	-0.59	-0.1	0.2	PCVX
DICE	0.55	-0.29	0.02	-0.43		0.47	0.79	0.45	-0.21	DICE
ETNB	0.26	0.09	0.69	-0.42	0.47		0.73	0.65	0.41	ETNB
MDGL	0.45	-0.33	0.2	-0.59	0.79	0.73		0.37	-0.04	MDGL
PLRX	0.5	0.24	0.44	-0.1	0.45	0.65	0.37		0.07	PLRX
STOK	-0.36	0.25	0.69	0.2	-0.21	0.41	-0.04	0.07		STOK
	ACLX	VTYX	IMCR	PCVX	DICE	ETNB	MDGL	PLRX	STOK

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

MDGL	+ 0.79	DICE
MDGL	+ 0.73	ETNB
ETNB	+ 0.69	IMCR
STOK	+ 0.69	IMCR
PLRX	+ 0.65	ETNB
DICE	+ 0.55	ACLX

High negative correlations

MDGL	- 0.59	PCVX
DICE	- 0.43	PCVX
ETNB	- 0.42	PCVX
STOK	- 0.36	ACLX
MDGL	- 0.33	VTYX
DICE	- 0.29	VTYX

Risk-Adjusted Indicators

There is a big difference between Morphic Stock performing well and Morphic Holding Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Morphic Holding's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ACLX	2.41	0.12	0.08	0.17	2.84	(2.57)	6.28	(5.68)	15.13
VTYX	3.36	0.09	0.08	0.15	3.12	(4.50)	6.96	(5.63)	16.88
IMCR	1.98	(0.25)	0.00	(0.12)	0.00	0.00	3.54	(4.18)	10.78
PCVX	2.25	0.48	0.10	(0.36)	2.19	(2.66)	3.32	(4.09)	42.81
DICE	2.09	0.67	0.30	(2.55)	1.14	(2.68)	5.66	(2.91)	37.64
ETNB	2.69	(0.25)	(0.01)	0.02	3.33	(3.24)	5.01	(6.35)	27.43
MDGL	2.70	0.44	0.15	1.41	2.13	(3.76)	5.17	(3.96)	30.27
PLRX	2.74	(0.14)	0.00	0.05	3.11	(2.94)	5.37	(5.55)	24.35
STOK	2.61	(0.33)	0.00	(0.13)	0.00	0.00	4.68	(6.99)	21.35

Unable to evaluate fundamental data of [ACLX, VTYX, IMCR, PCVX, DICE, ETNB, MDGL, PLRX, STOK, AKRO, TERN, INZY, VKTX, RVMD, RNA, PTGX] at this time. Please try again later

All Fundamental Data

Morphic Holding Competitive Analysis

The better you understand Morphic Holding competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Morphic Holding's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Morphic Holding's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	ACLX	VTYX	IMCR	PCVX	DICE	ETNB	MDGL	PLRX	STOK	AKRO
	1.12 88.07 Arcellx	1.13 2.68 Ventyx	0.27 32.74 Immunocore	0.38 94.34 Vaxcyte	0.62 46.97 Dice	1.64 8.99 89bio	0.98 328.19 Madrigal	2.00 13.80 Pliant	1.68 12.11 Stoke	0.22 32.10 Akero
Market Volatility (90 Days Market Risk)	Very steady	Somewhat reliable	Very steady	Very steady	Very steady	Somewhat reliable	Very steady	Not too volatile	Somewhat reliable	Very steady
Market Performance (90 Days Performance)	Good	Modest	Very Weak	Very Weak	Very Weak	Weak	OK	Insignificant	Very Weak	OK
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Below Average	Low	Below Average	Dangerous	Low	Low	Low	About Average	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Under Valued	Under Valued	Over Valued	Over Valued	Under Valued	Over Valued	Under Valued	Under Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Strong Buy	Strong Buy	Strong Buy	Strong Buy	Not Available	Strong Buy	Strong Buy	Strong Buy	Strong Buy	Strong Buy
Trade Advice (90 Days Macroaxis Advice)	Hold	Cautious Hold	Hold	Strong Sell	Not Rated	Sell	Buy	Cautious Hold	Cautious Hold	Hold
Current Ratio	10.16	14.27	3.98	11.94	23.61	5.81	2.55	7.69	10.46	6.9
Net Asset	825.13 M	277.69 M	597 M	1.41 B	593.98 M	596.27 M	640.55 M	512.15 M	228.34 M	580.27 M
Profit Margin	-0.26	N/A	-0.16	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA	(64.14 M)	(207.99 M)	(51.65 M)	(464.88 M)	(83.01 M)	(134.46 M)	(379.97 M)	(158.23 M)	(112.3 M)	(148.63 M)
Current Valuation	4.31 B	(76.41 M)	1.22 B	9.56 B	2.27 B	688.5 M	6.35 B	479.05 M	393.93 M	1.56 B
Price To Book	9.97	0.67	4.35	3.43	5.91	2.84	9.3	2.38	2.72	3.04
Operating Margin	-1.29	N/A	-0.11	N/A	N/A	N/A	-1.87	N/A	-6.13	N/A
Retained Earnings	(389.48 M)	(419.19 M)	(744.67 M)	(924.39 M)	(187.59 M)	(457.43 M)	(1.34 B)	(499.75 M)	(401.85 M)	(574.1 M)
Current Asset	N/A	N/A	N/A	N/A	N/A	10.12 M	363.58 K	N/A	N/A	22.85 M
Beta	0.27	0.37	0.72	1.01	N/A	0.98	-0.47	1.09	0.95	-0.26
Number Of Employees	130	75	497	254	71	70	376	166	110	60
Shares Outstanding	54.07 M	70.71 M	50.03 M	124.64 M	47.76 M	117.58 M	21.81 M	60.85 M	52.97 M	69.8 M
Cash Flow From Operations	207.57 M	(166.52 M)	2.94 M	(296.79 M)	(64.32 M)	(129.19 M)	(324.23 M)	(116.36 M)	(81.07 M)	(145.37 M)
Total Debt	97.62 M	12.51 M	84.03 M	29.22 M	13.27 M	27.11 M	117.19 M	11.37 M	2.06 M	26.3 M
Return On Equity	-0.11	-0.54	-0.13	-0.21	-0.22	-0.73	-1.3	-0.48	-0.52	-0.36
Return On Asset	-0.0629	-0.33	-0.0522	-0.15	-0.14	-0.41	-0.52	-0.28	-0.28	-0.23
Number Of Shares Shorted	4.45 M	8.55 M	7.6 M	9.69 M	4.88 M	5.52 M	4.43 M	7.29 M	6.4 M	3.62 M
Book Value Per Share	8.95	3.95	7.55	27.47	11.89	3.56	35.64	5.68	4.38	10.61
Current Liabilities	N/A	N/A	N/A	N/A	N/A	3.89 M	49.28 M	N/A	N/A	859.05 K
Total Asset	825.13 M	277.69 M	597 M	1.41 B	593.98 M	596.27 M	640.55 M	512.15 M	228.34 M	580.27 M
Debt To Equity	0.094	0.007	0.41	0.057	0.05	0.13	0.6	0.11	0.026	0.072
Short Ratio	6.67	9.33	30.92	7.66	1.26	6.55	7.65	17.28	15.55	6.02
Target Price	111.81	11.14	52.51	151.75	49.83	30.13	372.2	40.18	22.29	48.27
Shares Owned By Institutions	94.92	84.93	94.59	99.5	96.85	93.66	91.44	97.09	95.51	94.66
Market Capitalization	4.82 B	187.38 M	1.64 B	11.71 B	2.27 B	1.07 B	7.23 B	823.35 M	630.84 M	2.25 B
Price To Earning	N/A	N/A	N/A	N/A	N/A	-1.04	-13.96	N/A	N/A	-7.43
Price To Earnings To Growth	-0.07	N/A	N/A	-11.32	0.84	-0.45	N/A	N/A	0.27	0.93
Price To Sales	30.91	N/A	5.54	N/A	699.0	N/A	94.11	3050.34	37.68	N/A
Net Income	(70.69 M)	(192.96 M)	(43.37 M)	(402.27 M)	(83.89 M)	(142.19 M)	(373.63 M)	(161.34 M)	(104.7 M)	(151.76 M)
Earnings Per Share	-0.71	-2.35	-0.95	-4.6	-2.17	-2.96	-25.02	-3.35	-2.08	-3.78
Shares Owned By Insiders	12.62	4.01	5.23	0.5	3.15	0.58	8.56	2.91	4.49	5.34
Revenue	110.32 M	N/A	249.43 M	N/A	N/A	N/A	N/A	1.58 M	8.78 M	N/A
Working Capital	598.12 M	242.08 M	389.8 M	950.62 M	562.61 M	563.92 M	518.73 M	476.98 M	184.52 M	540.83 M
Cash And Equivalents	306.99 M	250.45 M	208.06 M	354.5 M	282.22 M	193.34 M	211.77 M	163.6 M	275.63 M	180.72 M
Cash Per Share	7.01	4.92	4.74	5.98	7.39	4.16	12.38	3.36	6.99	4.81
Gross Profit	N/A	N/A	54.11 M	(23 M)	(56.08 M)	N/A	N/A	9.69 M	12.4 M	N/A
Day Typical Price	88.32	2.64	32.9	93.56	46.88	9.04	327.61	13.69	12.06	32.28
Accumulation Distribution	5924.13	50136.95	3165.95	20659.48	0.0072	9221.62	4374.58	7339.05	6617.18	5171.0
Market Facilitation Index	0.0	N/A	0.0	0.0	0.34	0.0	0.0	0.0	0.0	0.0
Daily Balance Of Power	(0.41)	0.1579	(0.12)	0.1494	0.8529	(0.56)	(0.43)	0.5625	0.4348	(0.09)
Period Momentum Indicator	(1.00)	0.03	(0.09)	0.36	0.29	(0.15)	(3.26)	0.27	0.2	(0.07)
Rate Of Daily Change	0.99	1.01	1.0	1.0	1.01	0.98	0.99	1.02	1.02	1.0
Day Median Price	88.44	2.63	32.98	93.18	46.84	9.07	327.33	13.63	12.04	32.37
Price Action Indicator	(0.87)	0.07	(0.28)	1.35	0.27	(0.15)	(0.76)	0.31	0.17	(0.30)
Coefficient Of Variation	832.33	1256.04	(2,148)	1343.96	765.93	5164.52	924.82	3252.83	(2,217)	877.63
Mean Deviation	2.41	3.36	1.98	2.25	2.09	2.69	2.7	2.74	2.61	2.37
Jensen Alpha	0.1171	0.0891	(0.25)	0.4797	0.6726	(0.25)	0.4435	(0.14)	(0.33)	0.1306
Total Risk Alpha	(0.11)	(0.35)	(0.50)	(0.39)	(0.11)	(0.54)	(0.20)	(0.47)	(0.72)	(0.12)
Sortino Ratio	0.0795	0.0756	N/A	0.0995	0.2992	(0.01)	0.1518	(0)	N/A	0.0749
Downside Variance	10.62	11.67	N/A	6.17	3.12	11.45	5.87	11.05	N/A	9.07
Standard Deviation	3.2	4.82	2.48	5.01	5.01	4.02	4.56	3.83	3.64	3.08
Kurtosis	0.2817	6.89	0.123	42.22	44.89	5.37	13.39	5.66	2.39	(0.21)
Potential Upside	6.28	6.96	3.54	3.32	5.66	5.01	5.17	5.37	4.68	5.23
Treynor Ratio	0.1679	0.1515	(0.12)	(0.36)	(2.55)	0.0246	1.41	0.0499	(0.13)	0.187
Maximum Drawdown	15.13	16.88	10.78	42.81	37.64	27.43	30.27	24.35	21.35	13.37
Variance	10.25	23.21	6.15	25.07	25.06	16.2	20.8	14.66	13.21	9.49
Market Risk Adjusted Performance	0.1779	0.1615	(0.11)	(0.35)	(2.54)	0.0346	1.42	0.0599	(0.12)	0.197
Risk Adjusted Performance	0.0997	0.0694	(0.03)	0.0655	0.1085	0.0229	0.0912	0.0316	(0.03)	0.0948
Skewness	(0.14)	1.91	(0.29)	5.8	6.18	1.06	3.11	1.43	(0.77)	0.1744
Semi Deviation	2.84	3.12	N/A	2.19	1.14	3.33	2.13	3.11	N/A	2.66
Information Ratio	0.081	0.0536	(0.1)	0.0494	0.1055	(0.01)	0.0806	(0)	(0.08)	0.0732
Value At Risk	(5.68)	(5.63)	(4.18)	(4.09)	(2.91)	(6.35)	(3.96)	(5.55)	(6.99)	(4.45)
Expected Short fall	(2.57)	(4.50)	N/A	(2.66)	(2.68)	(3.24)	(3.76)	(2.94)	N/A	(2.46)
Downside Deviation	3.26	3.42	N/A	2.48	1.77	3.38	2.42	3.32	N/A	3.01
Semi Variance	8.05	9.74	N/A	4.81	1.29	11.06	4.56	9.66	N/A	7.07

Morphic Holding Competition Performance Charts

Five steps to successful analysis of Morphic Holding Competition

Morphic Holding's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Morphic Holding in relation to its competition. Morphic Holding's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Morphic Holding in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Morphic Holding's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Morphic Holding, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Morphic Holding position

In addition to having Morphic Holding in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Energy ETFs Thematic Idea Now

Energy ETFs

ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Energy ETFs theme has 92 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy ETFs Theme or any other thematic opportunities.

View All Next

Launch

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Consideration for investing in Morphic Stock

If you are still planning to invest in Morphic Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Morphic Holding's history and understand the potential risks before investing.

	Fundamental Analysis View fundamental data based on most recent published financial statements
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC